CENTENE CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CENTENE CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $194.78B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $163.07B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $154.00B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $144.55B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $125.98B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $111.12B | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $18.86B | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $18.98B | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $18.36B | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $18.44B | Feb 18, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $174.58B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $145.51B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $140.10B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $135.48B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $117.98B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $103.80B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $70.36B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $56.44B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $45.62B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $37.58B | Feb 19, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.21B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $17.07B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $17.64B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $16.92B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $14.49B | Feb 20, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($6.67B) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.31B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.70B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.20B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.35B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $1.81B | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | $209.00M | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | $95.00M | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | $495.00M | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | $522.00M | Feb 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($7.62B) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $3.18B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $2.93B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.32B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.78B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $3.08B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.78B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $1.46B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $1.26B | Feb 19, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.90B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $12.40B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $12.56B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $11.59B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $9.60B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $9.38B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $6.53B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $6.04B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $4.45B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $3.67B | Feb 19, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.09B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $154.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $8.05B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $6.26B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $4.21B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $5.50B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $1.48B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $1.23B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $1.49B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $1.85B | Feb 19, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $767.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $644.00M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $799.00M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $1.00B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $910.00M | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $869.00M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $730.00M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $675.00M | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $422.00M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $306.00M | Feb 19, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.75B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $82.45B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $84.64B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $76.87B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $78.38B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $68.72B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $40.99B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $30.90B | Feb 18, 2020 |
| FY2019 | Dec 31, 2017 | $21.86B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $20.20B | Feb 19, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.69B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $55.94B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $58.69B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $52.63B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $51.35B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $42.76B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $28.30B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $19.88B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $14.98B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $14.14B | Feb 20, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $19.95B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $26.41B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $25.84B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $24.06B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $26.80B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $25.77B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $12.55B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $10.92B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $6.85B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $5.90B | Feb 20, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.84B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $17.56B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $17.56B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $18.81B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $19.77B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $18.65B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $6.86B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $7.02B | Feb 22, 2021 |
| FY2019 | Dec 31, 2017 | $4.75B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $4.71B | Feb 19, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.67B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $15.35B | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $12.04B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $9.34B | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | $8.14B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $6.79B | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $4.98B | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | $3.66B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $2.75B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $1.92B | Feb 20, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.89B | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $14.06B | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $17.19B | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $12.07B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $13.12B | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | $10.80B | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $12.12B | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $5.34B | Feb 22, 2021 |
| FY2018 | Dec 31, 2017 | $4.07B | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | $3.93B | Feb 20, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.49B | Feb 17, 2026 |
| FY2024 | Dec 31, 2024 | $18.64B | Feb 18, 2025 |
| FY2023 | Dec 31, 2023 | $17.96B | Feb 20, 2024 |
| FY2022 | Dec 31, 2022 | $18.18B | Feb 21, 2023 |
| FY2021 | Dec 31, 2021 | $19.03B | Feb 22, 2022 |
| FY2020 | Dec 31, 2020 | $16.88B | Feb 22, 2021 |
| FY2019 | Dec 31, 2019 | $13.86B | Feb 18, 2020 |
| FY2018 | Dec 31, 2018 | $6.85B | Feb 19, 2019 |
| FY2017 | Dec 31, 2017 | $4.83B | Feb 20, 2018 |
| FY2016 | Dec 31, 2016 | $4.78B | Feb 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (13) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (13) | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 20, 2024 |
| FY2022 | Dec 31, 2020 | 3 | Feb 21, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 18, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 18, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 491.76M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 495.91M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | 534.48M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | 550.75M | Feb 20, 2024 |
| FY2022 | Dec 31, 2021 | 582.48M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 581.48M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 415.05M | Feb 22, 2021 |
| FY2019 | Dec 31, 2018 | 412.48M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 346.87M | Feb 19, 2019 |
| FY2017 | Dec 31, 2016 | 171.92M | Feb 20, 2018 |